Should atezolizumab be used with chemotherapy in the first line treatment of ES-SCLC?
Has the publication of IMpower133 changed standard of care?
Community PollStarted
Should atezolizumab be used with chemotherapy in the first line treatment of ES-SCLC?
85 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Cleveland Clinic
Answered on
Yes, as noted by the presenter of the results of IMpower 133 at WCLC, atezolizumab+ etoposide/carboplatin is a new standard of care for front-line therapy of ES-SCLC. This result should be embraced as it represents the first meaningful advance in the initial treatment of SCLC in decades. The reporte...
Join for free or sign in to see the full answer